MARKET

LLY

LLY

Lilly Eli & Co
NYSE
724.87
-7.33
-1.00%
After Hours: 727.05 +2.18 +0.30% 19:59 04/25 EDT
OPEN
725.00
PREV CLOSE
732.20
HIGH
727.99
LOW
718.30
VOLUME
2.61M
TURNOVER
0
52 WEEK HIGH
800.78
52 WEEK LOW
367.60
MARKET CAP
689.18B
P/E (TTM)
124.95
1D
5D
1M
3M
1Y
5Y
These Are The Biotechs Showing Up At The Biggest Cancer Meeting Of The Year (Oral Presentations)
Annual Meeting of the American Society of Clinical Oncology will be held in Chicago. The oral presentations will cover a range of topics including targeted therapies and immunologic therapies for various types of cancer. The plenary session will feature presentations on esophageal cancer, melanoma and lung cancer.
Seeking Alpha · 2h ago
Gear Up for Lilly (LLY) Q1 Earnings: Wall Street Estimates for Key Metrics
NASDAQ · 10h ago
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
NASDAQ · 11h ago
West Pharma posts beat-and-raise quarter aided by strong demand for injectables
West Pharma posts beat-and-raise quarter aided by strong demand for injectables. The company posted a first-quarter profit of $1.56 per share. West Pharmaceutical Services raised its annual profit forecast to $7.88 per share for 2024. Company expects sales growth to ramp up as the year progresses.
Reuters · 13h ago
Scholz promises support for pharma sector in Germany as Merck invests
German Chancellor Olaf Scholz promises support for pharma sector in Germany as Merck invests. Merck is investing 1.5 billion euros in Germany. The drugmaker plans to use its life sciences Advanced Research Centre in Darmstadt. Germany has sought to improve conditions for the pharma and biotech sector.
Reuters · 13h ago
LLY vs. JNJ: Which Big Pharma Stock Is Better?
I evaluated two big pharma stocks, Eli Lilly and Johnson & Johnson, using TipRanks’ Comparison Tool. Shares of Eli Lilly have surged 26% year-to-date and are up 92% over the last 12 months. A neutral view for Eli Lilly suggests a bullish view for Johnson and Johnson. Eli Lilly is trading at a much higher valuation than JNJ.
TipRanks · 20h ago
Will Higher Keytruda Sales Drive Merck's Q1
NASDAQ · 22h ago
Plaintiffs' lawyers chosen to lead Ozempic litigation
Plaintiffs' lawyers chosen to lead Ozempic litigation. Lawsuits allege companies failed to warn of harsh side effects associated with diabetes and weight loss drugs. A judge appointed eight plaintiffs' lawyers to leadership roles in federal mass tort litigation. The companies have said the claims are meritless.
Reuters · 1d ago
More
About LLY
Eli Lilly and Company is engaged in drug manufacturing businesses. The Company discovers, develops, manufactures and markets products in the human pharmaceutical products segment. Its diabetes, obesity and other cardiometabolic products include Basaglar, Humalog, Humulin, Jardiance, Mounjaro, Trulicity and Zepbound. Its oncology products include Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt and Verzenio. Its immunology products include Ebglyss, Olumiant, Omvoh and Taltz. Its neuroscience products include Cymbalta and Emgality. Its other products and therapies include Cialis and Forteo. The Company manufactures and distributes its products through facilities in the United States (U.S.), including Puerto Rico, and in Europe and Asia. The Company, through its subsidiary, POINT Biopharma Global Inc., is engaged in radiopharmaceutical discovery, development, and manufacturing, as well as clinical and pre-clinical radioligand therapies in development for the treatment of cancer.

Webull offers Eli Lilly And Co stock information, including NYSE: LLY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LLY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LLY stock methods without spending real money on the virtual paper trading platform.